Enroll Now
You Must LOG IN to Enroll
Publication Date: 20 July 2026
HEV and Blood Transfusion - Mitigating HEV & Transmission Risks in Blood Services
Continuing Education Credits: 0.5 hours
Course Description
In this lecture, Dr. Masahiro Satake provides an overview of the human hepatitis E virus (HEV), including its key characteristics, global distribution of variants, and clinical practice guidelines. He explains how HEV poses a risk to the blood supply and reviews documented cases of transfusion-transmitted infections in Japan, Germany, and the UK. The lecture concludes with a discussion on the implications for effective donor screening strategies.
Course Objectives
- Describe the global epidemiology of the Hepatitis E Virus (HEV)
- Discuss transfusion-transmitted-infection of HEV and effectiveness of ID-NAT screening for prevention
- Demonstrate HEV kinetics after infection and frequency of HEV infections in Japan
Run Time: 32:56
Course Instructor Bio(s)
Masahiro Satake, MD PhD
Former Director General, Japanese Red Cross (JRCS) Central Blood Institute & Executive Office
Tokyo, Japan
Dr. Satake received his Doctor of Medicine and PhD from Tohoku University School of Medicine, Japan. He completed his training for general surgery at Yamagata City Hospital. Prior to joining the JRCS in 1997, he practiced as a general surgeon with kidney and liver transplantation specialty in various hospitals. Since then, he has made significant contributions to enhancing the safety and efficacy of blood transfusion services in Japan, particularly in the prevention of Transfusion Transmitted Infections. He concluded his tenure as Director General of the JRCS Central Blood Institute in 2024. Following his retirement, Dr. Satake has remained actively engaged in advancing blood services in Japan.
